Skip to main content
SpringerLink
Log in

Policy Implications and Applications Across Health and Aged Care Reform with Baby Boomer Ageing - from Age and Dementia Friendly Communities to Palliative Care

  • Chapter
  • First Online:
Health Economics from Theory to Practice

Abstract

This chapter highlights policy application of health economic principles and methods introduced and developed in this book to current health and aged care issues and areas of policy reform challenges internationally, illustrated predominantly with Australian policy-related examples. In particular reform challenges posed for successful ageing of the baby boomer population within increasingly constrained budgets and consequent imperatives for being more efficient in use of existing technology and pricing and integration of new technology and related research, reimbursement and regulatory decisions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • ABS 2016. Life Tables, States, Territories and Australia, 2013–2015. ABS cat. no. 3302.0.55.001. Canberra: ABS.

    Google Scholar 

  • Access Economics. Making choices, Future dementia care: projections, problems and preferences. Report by Access Economics for Alzheimer’s Australia. 2009. https://www.fightdementia.org.au/sites/default/files/20090400_Nat__AE_FullMakingChoices.pdf.

  • Agar M. Antipsychotic medications for delirium don’t work and could harm, a new study shows. So what options are left? The Conversation. 2016. http://theconversation.com/drugs-for-delirium-dont-work-and-may-in-fact-harm-69143.

  • Agar M, Lawlor P, Quinn S, Draper B, Caplan BA, Rowett D, Sanderson C, Hardy J, Le B, Eckermann S, McCaffrey N, Devillee L, Fazekas B, Hill M, Currow DC. 2017. Efficacy of oral Risperidone, Haloperidol or Placebo for symptoms of delirium among patients in palliative care: a randomised trial. JAMA Intern Med. 2017 Jan 1;177(1):34–42. doi:10.1001/jamainternmed.2016.7491. First Published online December 5, 2016.

  • AIHW. 2015. Aged Care. viewed 18 Feb 2017, http://www.aihw.gov.au/aged-care/.

  • Alzheimer’s Disease International. Dementia friendly communities: key principles. London: Alzheimer’s Disease International; 2016.

    Google Scholar 

  • Al-Zaidy A. Models for paying providers: capitation. British Medical Association. 2015. https://www.bma.org.uk/connecting-doctors/policy_debate/new_integrated_care_models/m/bma_briefings. Accessed 6 July 2016.

  • A Place for Mom. Best practices for designing Alzheimer’s care facilities [internet]. Seattle: A Place for Mom; 2013 [updated 2013 April 4. Available from: http://www.aplaceformom.com/ senior-care-resources/articles/alzheimers-care-facilities.

  • Arrow KJ. Uncertainty and the welfare economics of medical care. Am Econ Rev. 1963;LIII(5):941–73.

    Google Scholar 

  • Australian Bureau of Statistics. Older people in cared accommodation. Canberra; 2007. https://www.abs.gov.au/ausstats.

  • Australian Bureau of Statistics. 2013a. Australian social trends 4102.0. http://www.abs.gov.au/AUSSTATS/abs@.nsf/Lookup/4102.0Main+Features20April+2013#p2.

  • Australian Bureau of Statistics. Disability, ageing and carers Australia, summary of findings 2012. 4430.0. 2013b. http://www.abs.gov.au/AUSSTATS/abs@.nsf/DetailsPage/4430.02012?OpenDocument.

  • Australian Bureau of Statistics, Population pyramid Australia to 2050. http://www.abs.gov.au/websitedbs/d3310114.nsf/home/Population%20Pyramid%20-%20Australia.

  • Australian Government Department of Health Office of Drug Control 2016. Guideline: security of medicinal cannabis V1.0 October 2016. https://www.odc.gov.au/sites/default/files/guideline-security-medicinal-cannabis.pdf.

  • Australian Institute of Health and Welfare. 25 years of health expenditure in Australia 1989–90 to 2013–14, Health & welfare exp series 56. Cat. no. HWE 66. Canberra: AIHW; 2016.

    Google Scholar 

  • Bachuber M et al. Medical Cannabis Laws and opioid analgesic overdose mortality in the United States, 1999-2010. JAMA Intern Med. 2014;174(10):1668–73.

    Google Scholar 

  • Bedrocan. 2016. http://www.bedrocan.nl/english/products.html. Accessed 21 Oct 2016.

  • Better. Better medical grade cannabis. 2017. http://www.better-global.com/en/doctors.

  • Bifulco M, Pisanti S. Medicinal use of cannabis in Europe: the fact that more countries legalize the medicinal use of cannabis should not become an argument for unfettered and uncontrolled use. EBMO Rep. 2015;16(2):130–2. doi:10.15252/embr.201439742.

    Google Scholar 

  • Bradford AC, Bradford WD. Medical marijuana laws reduce prescription medication use in Medicare Part D. Health Aff (Millwood). 2016;35:1230–1236. doi:10.1377/hlthaff.2015.1661. pmid:27385238.

  • Britt H, Miller GC, Henderson J, Charles J, Valenti L, Harrison C, Bayram C, Chambers T, et al. A decade of Australian general practice activity 2003–4 to 2012–13, General Practice Series number 34. Sydney: Sydney University Press; 2013.

    Google Scholar 

  • Brook C. Casemix funding for acute hospital care in Victoria, Australia. Victorian state government; 2002. Available at casemix.health.vic.gov.au/about casemix updated 1 October 2002. Last accessed 16 Sept 2003.

  • Buffel T, Phillipson C, Scharf T. Ageing in urban environments: developing ‘age-friendly’ cities. Crit Soc Policy. 2012;32(4):597–617.

    Article  Google Scholar 

  • Burgio L, Scilley K, Hardin MJ, Hsu C, Yancey J. Environmental “white noise”: an intervention for verbally agitated nursing home residents. J Gerontol Psychol Sci. 1996;51B:P364–73.

    Article  Google Scholar 

  • Butler JGR. Policy change and private health insurance: did the cheapest policy do the trick? Aust Health Rev. 2002;25(6):33–41.

    Article  Google Scholar 

  • Capezuti E, Strumpf NE, Evans LK, Grisso JA, Maislin G. The relationship between physical restraint removal and falls and injuries among nursing home residents. J Gerontol Med Sci. 1998;53A:M47–52.

    Article  Google Scholar 

  • Carter GT, Flanagan AM, Earleywine M, et al. Cannabis in palliative medicine: improving care and reducing opioid-related morbidity. Am J Hosp Palliat Care. 2011;28:297–303.

    Article  Google Scholar 

  • Caulkins JP. Estimated cost of production for legalized cannabis. Rand Corporation Working Paper 764, July 2010. 2010. Available online 21 July 2016: http://www.rand.org/content/dam/rand/pubs/working_papers/2010/RAND_WR764.pdf.

  • Charter D. For the Alzheimer’s victims lost in time, a new village of care. The Times 31 March 2012. 2012.

    Google Scholar 

  • Cohen-Mansfield J, Werner P. The effects of an enhanced environment on nursing home residents who pace. Gerontologist. 1998;38:199–208.

    Article  Google Scholar 

  • Colombo F, Tapay N. Private health insurance in OECD countries: the benefits and costs for individuals and health systems. In: Towards high-performing health systems. Paris (FRA): Organisation for Economic Co- operation and Development; 2004. Chap 6.

    Google Scholar 

  • Cooper. Growing medicinal cannabis is now legal in Australia. Huffington Post 30th October 2016. http://www.huffingtonpost.com.au/2016/10/30/growing-medicinal-cannabis-crops-is-now-legal-in-australia/.

  • Davis K, Stremikis K, Squires D, Schoen C. Mirror, mirror on the wall: how the performance of the U.S. Health Care System compares internationally: 2014 update. The Commonwealth Fund pub. no. 1755; 2014.

    Google Scholar 

  • de Bruin D, Ahmad T, Avendano JE, Sajanlal M, Edelstein A, Ryskin M. Medical cannabis has high potential: a joint biotech & tools primer. New York: Bank of America Merril Lynch; 2015.

    Google Scholar 

  • Deeble JS. Medicare: where have we been? Where are we going? Aust N Z J Public Health. 1999;23:563–70.

    Article  Google Scholar 

  • Dementia Village advisers. 2016. Accessed 17 Oct 2016 at http://www.dementiavillage.com.

  • Department of Health. Prime Minister’s challenge on dementia: delivering major improvements in dementia care and research by 2015. London: D.o.H. Publications. 2012; 2015.

    Google Scholar 

  • Department of Social Services. Home care packages program, Operational manual. Canberra; 2015.

    Google Scholar 

  • Dickinson JI, McLain-Kark J. Wandering behaviour and attempted exits among residents diagnosed with dementia-related illnesses: A qualitative approach. J Women Aging. 1998;10:23–35.

    Article  Google Scholar 

  • Eckermann S. Hospital Performance including quality: creating economic incentives consistent with evidence-based medicine. Ph.D. Dissertation, University of New South Wales; 2004. http://www.library.unsw.edu.au/~thesis/adt-NUN/public/adt-NUN20051018.135506/.

  • Eckermann S. Measuring health system efficiency and funding for net benefit maximisation: the health economics of quality of care. Clinical Change Working Paper number 4; 2009a. http://clinicalchange.flinders.edu.au/publications.html.

  • Eckermann S. Funding to maximise quality of care within a budget: bringing net benefit to casemix funding. Clinical Change Working Paper number 5; 2009b. http://clinicalchange.flinders.edu.au/publications.html.

  • Eckermann S. Over and underservicing: further reasons to scrap the GP co-payment. The Conversation, August 7 2014. 2014a. http://theconversation.com/over-and-under-servicing-further-reasons-to-scrap-the-gp-co-payment-30199.

  • Eckermann S. Avoiding a health system hernia and the associated outcomes and costs. ANZJ Public Health. 2014b;38(4):303–5.

    Google Scholar 

  • Eckermann S, Coelli T. Including quality attributes in efficiency measures consistent with net benefit: creating incentives for evidence based medicine in practice. Soc Sci Med. 2013;76:159–68.

    Article  Google Scholar 

  • Eckermann S, Pekarsky B. Can the real opportunity cost stand up: displaced services the straw man outside the room. PharmacoEconomics. 2014;32(4):319–25. http://www.springerlink.com/openurl.asp?genre=article&id=doi:10.1007/s40273-014-0140-3.

  • Eckermann S, Sheridan L. Supporting medicare health, equity and efficiency in Australia: policies undermining bulk billing need to be scrapped. Applied Health Economics and Health Policy; 2016. Published online 20 July 2016 available at http://link.springer.com/article/10.1007%2Fs40258-016-0258-x.

  • Eckermann S, Willan AR. Expected value of information and decision making in HTA. Health Econ. 2007;16:195–209.

    Article  Google Scholar 

  • Eckermann S, Willan AR. The option value of delay in health technology assessment. Med Decis Making. 2008a;28:300–5.

    Article  Google Scholar 

  • Eckermann S, Willan AR. Time and EVSI wait for no patient. Value Health. 2008b;11:522–6.

    Article  Google Scholar 

  • Eckermann S, Willan AR. Globally optimal trial design for local decision making. Health Econ. 2009;18:203–16.

    Article  Google Scholar 

  • Eckermann S, Willan A. Presenting evidence and summary measures to best inform societal decisions when comparing multiple strategies. Pharmacoeconomics. 2011;29(7):563–77.

    Google Scholar 

  • Eckermann S, Willan A. Optimal global VOI trials: better aligning manufacturer and decision maker interest and enabling feasible risk sharing. Pharmacoeconomics. 2013;31:393–401.

    Article  Google Scholar 

  • Eckermann S, Briggs A, Willan A. Health technology assessment in the cost- disutility plane. Med Decis Making. 2008;28:172–81.

    Article  Google Scholar 

  • Eckermann S, Coory, M, Willan AR. Indirect comparison: relative risk fallacies and odds solution. J Clin Epidemiol. 2009. Published Online: January 2009. doi:10.1002/hec.1353.

  • Eckermann S, Karnon J, Willan AR. The value of value of information: best informing research design and prioritization using current methods. Pharmacoeconomics. 2010;28(9):699–709.

    Article  Google Scholar 

  • Eckermann S, Coory M, Willan A. Consistently estimating absolute risk difference when translating evidence to jurisdictions of interest. Pharmacoeconomics. 2011;29(2):87–96.

    Article  Google Scholar 

  • Eckermann S, Dawber J, Yeatman H, Quinsey K, Morris D. Evaluating return on investment in a school based health promotion and prevention program: the investment multiplier for the Stephanie Alexander Kitchen Garden National Program. Soc Sci Med. 2014;114:103–12. doi:10.1016/j.socscimed.2014.05.056.

    Article  Google Scholar 

  • Eckermann S, Sheridan L, Ivers R. Which direction should Australian health system reform be heading? ANZJ Public Health. 2016;40(1):7–9.

    Google Scholar 

  • Ellis R, Savage E. Run for cover now or later? The impact of premiums, threats and deadlines on private health insurance in Australia. Int J Health Care Finance Econ. 2008;8(4):257–77.

    Article  Google Scholar 

  • Fernandes E. Dementiaville: how an experimental new town is taking the elderly back to their happier and healthier pasts with astonishing results. Daily Mail, 5 March 2012. 2012. Available online 14 October 2016 at: http://www.dailymail.co.uk/news/article-2109801/Dementiaville-How-experimental-new-town-taking-elderly-happier-healthier-pasts-astonishing-results.html#ixzz4N1BDZz2K.

  • Fleming R. Improving the design of facilities for people with dementia. Austr J Dementia Care. 2013;1(4):35–7.

    Google Scholar 

  • Fleming R, Bennett K. The dementia friendly community environmental assessment tool. University of Wollongong; 2015. http://www.enablingenvironments.com.au/audit-tools/http://www.enablingenvironments.com.au/uploads/5/0/4/5/50459523/alzheimers_enviro_assess_tool_a4-signoff.pdf.

  • Fleming R, Purandere N. Long-term care for people with dementia: environmental design guidelines. Int Psychogeriatr. 2010;22(7):1084–96.

    Article  Google Scholar 

  • Fleming R, Cookes PA, Sum S. A review of the empirical literature on the design of physical environments for people with dementia. 2008. Retrieved from: http://ro.uow.edu.au/cgi/viewcontent.cgi?article=3923&context=hbspapers.

  • Fuchs VR. Though much is taken’: reflections on aging, health, and medical care. Milbank Memorial Fund Q/Health Soc. 1984;62(2):143–66.

    Google Scholar 

  • Gallily R, Yekhtin Z, Ondřej HL. Overcoming the bell-shaped dose-response of cannabidiol by using cannabis extract enriched in cannabidiol. Pharmacol Pharm. 2015;6:75–85.

    Article  Google Scholar 

  • Glendinning C. Home care in England: markets in the context of under-funding. Health Soc Care Community. 2012:292–9.

    Google Scholar 

  • Godwin B. I did it! Did you see. J Dementia Care. 2004;12(6):16–7.

    Google Scholar 

  • Godwin B. Hogewey: a ‘home from home’ in the Netherlands. J Dementia Care. 2015;23(3):28–31.

    Google Scholar 

  • Godwin B, Walters H. In solitary confinement: planning end of life wellbeing with people with advanced dementia, their family and professional carers. Mortality. 2009;14(3):265–85.

    Article  Google Scholar 

  • Goss J, Eckermann S and Pinyopusarerk M. Health care for the elderly: costs and some institutional issues. In: EPAC, economic and social consequences of Australia’s ageing population, preparing for 21st century. Canberra: AGPS; 1992.

    Google Scholar 

  • Gotestam KG, Melin L. Improving well-being for patients with senile dementia by minor changes in the ward environment. In: Levi L, editor. Society, stress, and disease. Oxford: Oxford University Press; 1987. p. 295–7.

    Google Scholar 

  • Grotenhermen F, Müller-Vahl K. The therapeutic potential of cannabis and cannabinoids. Dtsch Arztebl Int. 2012;109(29–30):495–501. Epub 2012 Jul 23

    Google Scholar 

  • Hardy J, Quinn S, Fazekas B, Plummer J, Eckermann S, Agar M, Spruyt O, Rowett D, Currow D. A randomised, double-blind placebo controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain. J Clin Oncol. 2012;30(29):3611–7.

    Article  Google Scholar 

  • Harris J. The internal organization of hospitals: some economic implications. Bell J Econ. 1977;8:467–82.

    Article  Google Scholar 

  • Harris A. Things you should know about the private health insurance rebate. The Conversation. 2013.

    Google Scholar 

  • Harrison C, Byram C, Miller G, Britt H. The cost of freezing general practice. Med J Aust. 2015;202(6):313–6.

    Article  Google Scholar 

  • Hawe P, Shiell A. Social capital and health promotion: a review. Soc Sci Med. 2000;51(6):871e885.

    Article  Google Scholar 

  • Hawe P, Shiell A, Riley T. Theorising interventions as events in systems. Am J Community Psychol. 2009;43(3e4):267–76.

    Article  Google Scholar 

  • Helms T, Newhouse JP, Phelps CE. Copayments and demand for medical care. The California Medicaid experience. Bell J Econ. 1978;9(1):192–208.

    Article  Google Scholar 

  • IHPA 2016. Available at: https://www.ihpa.gov.au/who-we-are.

  • International Longevity Centre Brazil. Active ageing: a policy framework in response to the longevity revolution. International Longevity Centre Brazil. Ist Edition. Rio de Janeiro; 2015. Available 14 Oct 2016 at: http://ilcbrazil.org/news/active-ageing-a-policy-framework-in-response-to-the-longevity-revolution/.

  • Johnson JR, Burnell-Nugent M, Lossignol D, Ganae-Motan ED, Potts R, Fallon MT. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage 2010;39(2):167–179. doi: 10.1016/j.jpainsymman.2009.06.008. Epub 2009 Nov 5.

  • Kalache A. The longevity revolution: creating a society for all ages. Adelaide thinker in residence 2012–2013. Adelaide: Government of South Australia; 2013. Available at: http://www.flinders.edu.au/sabs/fcas-files/Publications/The%20Longevity%20Revolution.pdf.

  • Kitwood T. Towards a theory of dementia care: Ethics and interaction. J Clin Ethics. 1998;9(1):723–34.

    Google Scholar 

  • Kremer P. Alzheimer: Une vie presque ordinaire. Le Monde, 13 November 2013. 2013

    Google Scholar 

  • Lee J. Senate passes medicinal cannabis legislation. Sydney Morning Herald, 24 February, 2016. 2016. http://www.smh.com.au/federal-politics/political-news/senate-passes-medicinal-cannabis-legislation-20160224-gn2gjk.html.

  • Lindenauer P, Remus D, Roman S, Rothberg M, Benjam E, Ma A, Bratzler D. Public reporting and pay for performance in hospital quality improvement. New Eng J Med. 2007;356(5):486–96.

    Article  Google Scholar 

  • Locke JM, Stutchbury TK, Vine KL, Gamble AB, Clingan PR, Bremner JB, Ranson M. Development and assessment of novel all-in-one parenteral formulations with integrated anticoagulant properties for the concomitant delivery of 5-fluorouracil and calcium folinate. Anticancer Drugs. 2009;20:822–31.

    Article  Google Scholar 

  • Lu L, Pearce H, Roome C, Shearer J, Lang IA, Stein K. Cost effectiveness of oromucosal cannabis-based medicine (Sativex®) for spasticity in multiple sclerosis. Pharmacoeconomics. 2012;30(12):1157–71.

    Article  Google Scholar 

  • Lubitz J, Riley G. Trends in medicare payments in the last year of life. N Engl J Med. 1993;328:1092–6.

    Article  Google Scholar 

  • Lyapustina T, Alexandre GC. The prescription opioid addiction and abuse epidemic: how it happened and what we can do about it. Pharma J. 2015. http://www.pharmaceutical-journal.com/opinion/comment/the-prescription-opioid-addiction-and-abuse-epidemic-how-it-happened-and-what-we-can-do-about-it/20068579.article.

  • Mather LE, Rauwendaal ER, Moxham-Hall VL, Wodak AD. (Re)introducing medicinal cannabis. Med J Aust. 2013;199(11):759–61. doi:10.5694/mja13.10728.

    Article  Google Scholar 

  • Maust DT, Kales HC. Medicating distress. JAMA Intern Med. 2017;177(1):42–3. doi:10.1001/jamainternmed.2016.7528. First published online December 5, 2016.

  • Maust DT, Kim HM, Seyfried LS. Antipsychotics, other psychotropics and the risk of death in patients with dementia: number needed to harm. JAMA Psychiat. 2015;72(5):438–45.

    Article  Google Scholar 

  • May J. The new age of old age. Sydney Morning Herald. May 1, 2012. 2012. Accessed 14 Oct 2016 at: http://www.smh.com.au/national/the-new-age-of-old-age-20120430-1xuzb.html#ixzz45MDtfdyS.

  • McCaffrey N. Modelling joint cost and outcomes uncertainty on the cost-disutility plane – case studies in palliative care. PhD, Flinders University; 2013.

    Google Scholar 

  • McCaffrey N, Skuza P, Breaden K, Eckermann S, Hardy J, Oaten S, Briffa M, Currow D. Preliminary development and validation of a new end-of-life patient-reported outcome measure assessing the ability of patients to finalise their affairs at the end of life. PLoS One. 2014;9(4):e94316. doi:10.1371/journal.pone.0094316.

    Article  Google Scholar 

  • McCaffrey N, Agar M, Harlum J, Karnon J, Currow D, Eckermann S. Better informing decision making with multiple outcomes cost-effectiveness analysis under uncertainty in cost-disutility space. PLoS One. 2015;10(3):e0115544. doi:10.1371/journal.pone.0115544.

    Article  Google Scholar 

  • McCaffrey N, Bradley S, Ratcliffe J, Currow DC. What aspects of quality of life are important from palliative care patients’ perspectives? A systematic review of qualitative research. J Pain Symptom Manage. 2016. pii S0885–3924(16)30078–1. doi:10.1016/j.jpainsymman.2016.02.012. [Epub ahead of print].

  • McKay M, Thompson C, Ward D, Green D, Campbell D, McDonell G, et al. GP copayments would increase emergency department waiting times. The Conversation. 2014. http://theconversation.com/gp-co-payment-would-increase-emergency-department-wait-times-28658.

  • Minde R, Haynes E, Rodenburg M. The ward milieu and its effect on the behaviour of psychogeriatric patients. Can J Psychiatry. 1990;35:133–8.

    Google Scholar 

  • Mooney G. The health of nations: towards a new political economy. London: Zed books; 2012.

    Google Scholar 

  • Morgan DG, Stewart MJ. Multiple occupancy versus private rooms on dementia care units. Environ Behav. 1998;30:487–504.

    Article  Google Scholar 

  • National Hospital performance Authority. Closure of the National Health Performance Authority. 2016. Accessed 21 Oct 2016 at http://www.nhpa.gov.au/internet/nhpa/publishing.nsf.

  • Newton C. How can we best design housing for Australia’s ageing population? The Conversation. 2015. http://theconversation.com/how-can-we-best-design-housing-for-australias-ageing-population-50304.

  • Oldham J, December 21 2015. http://www.bloomberg.com/news/articles/2015-12-21/as-pot-growing-expands-power-demands-tax-u-s-electricity-grids.

  • Organisation for Economic Co-operation and Development (OECD). Health at a glance 2013: OECD indicators. Paris: OECD Publishing; 2013.

    Google Scholar 

  • Parliament of Australia. Report: National Health Reform Amendment (Independent Hospital Pricing Authority) Bill. 2011. www.aph.gov.au/Parliamentary_Business/...13/nhpa/.../nhpa/.../c01.ashx.

  • Parliament of Australia (2014). Budget papers 2014–15. Retrieved July 25, 2015 from http://www.budget.gov.au/2014-15/content/bp1/html/index.htm.

  • Peacock SJ, Richardson JR. Supplier-induced demand: re-examining identification and misspecification in cross-sectional analysis. Eur J Health Econ. 2007;8(3):267–77.

    Google Scholar 

  • Pekarsky BAK. Trusts, constraints and the counterfactual: reframing the political economy of new drug price. Dissertation, University of Adelaide; 2012.

    Google Scholar 

  • Pekarsky BAK. The new drug reimbursement game: a regulator’s guide to playing and wining. London: Springer; 2015.

    Google Scholar 

  • Phillipson L. Making flexible respite a practical reality. Key note address at Alzheimer’s Australia National Respite Summit. Ryde, NSW, April 1 2016; 2016.

    Google Scholar 

  • Phillipson L, Hall D, Cridland L, Fleming R, Brennan-Horley C. Dementia-friendly Kiama. Final evaluation report. October, 2016. University of Wollongong; 2016.

    Google Scholar 

  • Pick R. 16th February 2016. Motherboard.http://motherboard.vice.com/read/growing-marijuana-uses-1-percent-of-americas-total-electricity-industry-says.Private health Insurance Administration Council. Quarterly statistics march 2014. Canberra: Commonwealth of Australia; 2014.

    Google Scholar 

  • Procon.org. 23 Legal Medical Marijuana States and DC: Laws, Fees, and Possession Limits. Accessed 7th February 2016 at: http://medicalmarijuana.procon.org/view.resource.php?resourceID=000881.

  • Procon.org. 28 Legal Medical Marijuana States and DC: Laws, Fees, and Possession Limits. Accessed 5th March 2017 at: http://medicalmarijuana.procon.org/view.resource.php?resourceID=000881.

  • Productivity Commission. Implications of an ageing Australia: cost of death and health expenditure. Productivity Commission Technical paper 13. Canberra; 2006.

    Google Scholar 

  • Productivity Commission. Caring for older Australians. 2011. http://www.pc.gov.au/inquiries/completed/aged-care.

  • Richardson JR, Peacock SJ. Supplier-induced demand: reconsidering the theories and new Australian evidence. Appl Health Econ Health Policy. 2006;5(2):87–98.

    Google Scholar 

  • Roxon N. 2011. Second reading speech: National Health Reform Amendment (National HealthPerformance Authority) Bill 2011, 3 March 2011 p. 219, viewed 18 Feb 2017. http://parlinfo.aph.gov.au/parlInfo/search/display/display.w3p;query=Id%3A%22chamber%2Fhansardr%2F2011-03-03%2F0012%22.

  • Russo EB. Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344–64.

    Google Scholar 

  • Ruta D, Mitton C, Bate A, Donaldson C. Programme budgeting and marginal analysis: bridging the divide between doctors and managers. BMJ. 2005;330(7506):1501–3. doi:10.1136/bmj.330.7506.1501.

    Article  Google Scholar 

  • Seshamani M, Gray A. Time to death and health expenditure: an improved model for the impact of demographic change on health care costs. Age Ageing. 2004;33(6):556–61.

    Article  Google Scholar 

  • Sevcenko M. The Guardian. 2016. http://www.theguardian.com/us-news/2016/feb/27/marijuana-industry-huge-energy-footprint.

  • Shiell A, Hawe P. Health promotion community development and the tyranny of individualism. Health Econ. 1995;5(3):241e247.

    Google Scholar 

  • Shiell A, Hawe P, Gold L. Complex interventions or complex systems? Implications for health economic evaluation. Br Med J. 2008;336(7656):1281e1283.

    Article  Google Scholar 

  • Simon H. A behavioral model of rational choice. In:Models of man, social and rational: mathematical essays on rational human behavior in a social setting. New York: Wiley; 1957.

    Google Scholar 

  • Sloane PD, Mathew LJ, Scarborough M, Desai JR, Koch GG, Tangen C. Physical and pharmacologic restraint of nursing home patients with dementia. Impact of specialized units. JAMA. 1991;265(10):1278–82.

    Article  Google Scholar 

  • Stewart JT. Management of behaviour problems in the demented patient. Am Fam Physician. 1995;52:2311–20.

    Google Scholar 

  • Stutchbury TK, Vine KL, Locke JM, Chrisp JS, Bremner JB, Clingan PR, Ranson M. Preclinical evaluation of novel all-in-one formulations of 5-fluorouracil and folinic acid with reduced toxicity profiles. Anticancer Drugs. 2011;22:24–34.

    Article  Google Scholar 

  • Swerissen H, Duckett S. Dying well. Grattan Institute; 2014. ISBN: 978–1–925015-61-4

    Google Scholar 

  • Tagliabue J. Taking on Dementia with the Experiences of Normal Life. New York Times April 25 2012; 2012. Accessed 14 Oct 2016 at: http://www.nytimes.com/2012/04/25/world/europe/netherlands-hogewey-offers-normal-life-to-dementia-patients.html?_r=0.

  • Tikun O. Tikun Olam Medicinal Cannabis; 2016. http://www.tikun-olam.info/. Last viewed 21 Oct 2016.

  • Tinker B. ‘Dementia village’ inspires new care. CNN December 27, 2013; 2013. http://edition.cnn.com/2013/07/11/world/europe/wus-holland-dementia-village/.

  • Trivedi A, Moloo H, Mor V. Increased ambulatory care copayments and hospitalizations among the elderly. N Engl J Med. 2010. 28;362(4):320–8. doi: 10.1056/NEJMsa0904533.

    Google Scholar 

  • USA National Academy of Science. 2017. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington DC. The National Academies Press. https://doi.org/10.17226/24625.

    Google Scholar 

  • van Dijk CE, van den Berg B, Verheij RA, Spreeuwenberg P, Groenewegen PP, de Bakker DH. Moral hazard and supplier-induced demand: empirical evidence in general practice. Health Econ. 2013;22(3):340–52. doi:10.1002/hec.2801. Epub 2012 Feb 20.

    Google Scholar 

  • Wagner H, Ulrich-Merzenich G. Synergy research: approaching a new generation of phytopharmaceuticals. Phytomedicine. 2009;16:97–110.

    Google Scholar 

  • Willan AR, Eckermann S. Expected value of information and pricing new health care interventions. PharmacoEconomics. 2012;30(6):447–59.

    Google Scholar 

  • Wilson RM, Runciman WB, Gibberd RW, et al. The Quality in Australian Health Care Study. Med J Aust 1995; 163: 458–471.

    Google Scholar 

  • Wilson RM, Harrison BT, Gibberd RW and Hamilton JD.An analysis of the causes of adverse events from the Quality in Australian Health Care Study. MJA 1999; 170: 411–415.

    Google Scholar 

  • World Health Organisation. Active aging: a policy framework. Geneva: WHO; 2002a

    Google Scholar 

  • World Health Organisation. Active ageing: a policy framework. Geneva: World Health Organization; 2002b.

    Google Scholar 

  • World Health Organisation. Global age-friendly cities, a guide. Geneva: World Health Organization; 2007.

    Google Scholar 

  • World Health Organization and Alzheimer’s Disease International. Dementia: a public health priority. Geneva: WHO; 2012. Available at: http://www.who.int/mental_health/publications/dementia_report_2012/en/.

  • Yeatman H, Quinsey K, Dawber J, Nielsen W, Condon-Paoloni D, Eckermann S, Morris D, Grootemaat P, Fildes D. Stephanie Alexander Kitchen Garden National Program Evaluation: final report. Wollongong: Centre for Health Service Development, Australian Health Services Research Institute, University of Wollongong; 2013.

    Google Scholar 

  • Yeatman H, Quinsey K, Dawber J, Nielsen W, Condon-Paoloni D, Eckermann S, Morris D, Grootemaat P, Fildes D. Combining realism with rigour: evaluation of a National Kitchen Garden program in Australia primary schools evaluation. J Australasia. 2014;14(2):17–24.

    Google Scholar 

  • Zeisel J. Inquiry by design-environment/behaviour/neuroscience in architecture, interiors, landscape and planning -foreword by John b. Eberhard. Revised edition. New York: W.W. Norton & Company, Inc; 2006.

    Google Scholar 

  • Zeisel J, Silverston N, Hyde J, Levkoff S, Lawton MP, Holmes W. Environmental correlates to behavioural health outcomes in Alzeimers special care units. Gerontologist. 2003;43(5):697–711. doi:10.1093/geront/43.5.697.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Health Economics, University of Wollongong, Wollongong, New South Wales, Australia

    Simon Eckermann

Authors
  1. Simon Eckermann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Eckermann, S. (2017). Policy Implications and Applications Across Health and Aged Care Reform with Baby Boomer Ageing - from Age and Dementia Friendly Communities to Palliative Care. In: Health Economics from Theory to Practice. Adis, Cham. https://doi.org/10.1007/978-3-319-50613-5_12

Download citation

Publish with us

Policies and ethics

Search

Navigation